Catalyst Pharmaceuticals (CPRX) Prepaid Assets (2010 - 2026)
Catalyst Pharmaceuticals (CPRX) posted Prepaid Assets of $1.1 million for Q1 2026, down 80.88% on a QoQ basis from $5.9 million in Q4 2025, and down 1.48% year-over-year from $1.1 million in Q1 2025.
Catalyst Pharmaceuticals (CPRX) Prepaid Assets (2010 - 2026) Analysis & Trends
Catalyst Pharmaceuticals' Prepaid Assets history runs 17 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- Quarterly Prepaid Assets fell 1.48% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 1.48% YoY) and the FY2025 annual result came in at $5.9 million, down 25.67% from the prior year.
- Prepaid Assets was $1.1 million for Q1 2026 at Catalyst Pharmaceuticals, down from $5.9 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $28.1 million in Q3 2025 and bottomed at $351000.0 in Q4 2023.
- A 5-year average of $7.7 million and a median of $5.2 million in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets plunged 96.5% — and 2025, when it jumped 5651.12%.
- Catalyst Pharmaceuticals' Prepaid Assets stood at $5.2 million in 2022, then sank by 93.21% to $351000.0 in 2023, then soared by 2167.52% to $8.0 million in 2024, then retreated by 25.67% to $5.9 million in 2025, then tumbled by 80.88% to $1.1 million in 2026.
- Business Quant data shows CPRX's Prepaid Assets at $1.1 million in Q1 2026, $5.9 million in Q4 2025, and $28.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | 5.92 Mn |
| Sep 30, 2025 | 28.12 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 7.96 Mn |
| Sep 30, 2024 | 489,000.00 |
| Jun 30, 2024 | 23.55 Mn |
| Mar 31, 2024 | 13.75 Mn |
| Dec 31, 2023 | 351,000.00 |
| Sep 30, 2023 | 13.96 Mn |
| Jun 30, 2023 | 8.63 Mn |
| Mar 31, 2023 | 6.93 Mn |
| Dec 31, 2022 | 5.17 Mn |
| Sep 30, 2022 | 3.78 Mn |
| Jun 30, 2022 | 4.33 Mn |
| Mar 31, 2022 | 5.02 Mn |
| Dec 31, 2021 | 4.35 Mn |
| Sep 30, 2021 | 4.43 Mn |
| Jun 30, 2021 | 7.64 Mn |